Postmastectomy Radiation Therapy: An Overview for the Practicing Surgeon
Author:
Open Access
- 11 September 2013
- journal article
- review article
- Published by Hindawi Limited in ISRN Surgery
- Vol. 2013, 1-16
Abstract
Locoregional control of breast cancer is the shared domain and responsibility of surgeons and radiation oncologists. Because surgeons are often the first providers to discuss locoregional control and recurrence risks with patients and because they serve in a key gatekeeping role as referring providers for radiation therapy, a sophisticated understanding of the evidence regarding radiotherapy in breast cancer management is essential for the practicing surgeon. This paper synthesizes the complex and evolving evidence regarding the role of radiation therapy after mastectomy. Although substantial evidence indicates that radiation therapy can reduce the risk of locoregional failure after mastectomy (with a relative reduction of risk of approximately two-thirds), debate persists regarding the specific subgroups who have sufficient risks of residual microscopic locoregional disease after mastectomy to warrant treatment with radiation. This paper reviews the evidence available to guide appropriate referral and patient decision making, with special attention to areas of controversy, including patients with limited nodal disease, those with large tumors but negative nodes, node-negative patients with high risk features, patients who have received systemic chemotherapy in the neoadjuvant setting, and patients who may wish to integrate radiation therapy with breast reconstruction surgery.Keywords
This publication has 115 references indexed in Scilit:
- Proton radiotherapy for chest wall and regional lymphatic radiation; dose comparisons and treatment deliveryRadiation Oncology, 2013
- Predictors of Locoregional Recurrence After Neoadjuvant Chemotherapy: Results From Combined Analysis of National Surgical Adjuvant Breast and Bowel Project B-18 and B-27Journal of Clinical Oncology, 2012
- Patterns and Correlates of Adjuvant Radiotherapy Receipt After Lumpectomy and After Mastectomy for Breast CancerJournal of Clinical Oncology, 2010
- Risk of Second Malignancies After Adjuvant Radiotherapy for Breast Cancer: A Large-Scale, Single-Institution ReviewInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2007
- Late Cardiac Mortality and Morbidity in Early-Stage Breast Cancer Patients After Breast-Conservation TreatmentJournal of Clinical Oncology, 2006
- Low Locoregional Recurrence Rate Among Node-Negative Breast Cancer Patients With Tumors 5 cm or Larger Treated by Mastectomy, With or Without Adjuvant Systemic Therapy and Without Radiotherapy: Results From Five National Surgical Adjuvant Breast and Bowel Project Randomized Clinical TrialsJournal of Clinical Oncology, 2006
- Implant Reconstruction in Breast Cancer Patients Treated with Radiation TherapyPlastic and Reconstructive Surgery, 2006
- Morbidity of immediate breast reconstruction (IBR) after mastectomy by a subpectorally placed silicone prosthesis:the adverse effect of radiotherapyEuropean Journal of Surgical Oncology, 2000
- Postsurgical adjuvant chemotherapy with or without radiotherapy in women with breast cancer and positive axillary nodes: a South-Eastern Cancer Study Group (SEG) trialEuropean Journal of Cancer, 1992
- Results in patients with breast cancer treated by radical mastectomy and postoperative irradiation with no adjuvant chemotherapyCancer, 1982